نتایج جستجو برای: erg gene expression

تعداد نتایج: 1609450  

2011
Vera Magistroni Luca Mologni Stefano Sanselicio James Frances Reid Sara Redaelli Rocco Piazza Michela Viltadi Giorgio Bovo Guido Strada Marco Grasso Manuela Gariboldi Carlo Gambacorti-Passerini

The ERG gene belongs to the ETS family of transcription factors and has been found to be involved in atypical chromosomal rearrangements in several cancers. To gain insight into the oncogenic activity of ERG, we compared the gene expression profile of NIH-3T3 cells stably expressing the coding regions of the three main ERG oncogenic fusions: TMPRSS2/ERG (tERG), EWS/ERG and FUS/ERG. We found tha...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Sarah Minner Malaika Enodien Hüseyin Sirma Andreas M Luebke Antje Krohn Pascale S Mayer Ronald Simon Pierre Tennstedt Julia Müller Laura Scholz Jan C Brase Alvin Y Liu Hartmut Schlüter Klaus Pantel Udo Schumacher Carsten Bokemeyer Thomas Steuber Markus Graefen Guido Sauter Thorsten Schlomm

PURPOSE About 50% of prostate cancers have TMPRSS2-ERG fusions with concurrent ERG overexpression. The aim of this study was to determine whether clinical differences exist between ERG-positive and ERG-negative cancers in surgically treated patients not exposed to antihormonal therapy. A secondary aim was to search for differences between these tumor classes. EXPERIMENTAL DESIGN A tissue micr...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Karin G Hermans Joost L Boormans Delila Gasi Geert J H L van Leenders Guido Jenster Paul C M S Verhagen Jan Trapman

PURPOSE To gain insight in the mechanism and clinical relevance of TMPRSS2-ERG expression in prostate cancer, we determined the specific characteristics of fusion transcripts starting at TMPRSS2 exon 1 and at a more upstream and less characterized exon 0. EXPERIMENTAL DESIGN We used quantitative PCR analysis to investigate expression of wild-type TMPRSS2(exon 0) and TMPRSS2(exon 1) and of ERG...

2013
Petra Massoner Karl G. Kugler Karin Unterberger Ruprecht Kuner Laurin A. J. Mueller Maria Fälth Georg Schäfer Christof Seifarth Simone Ecker Irmgard Verdorfer Armin Graber Holger Sültmann Helmut Klocker

ERG gene rearrangements are found in about one half of all prostate cancers. Functional analyses do not fully explain the selective pressure causing ERG rearrangement during the development of prostate cancer. To identify transcriptional changes in prostate cancer, including tumors with ERG gene rearrangements, we performed a meta-analysis on published gene expression data followed by validatio...

Journal: :The Journal of clinical investigation 2013
Changmeng Cai Hongyun Wang Housheng Hansen He Sen Chen Lingfeng He Fen Ma Lorelei Mucci Qianben Wang Christopher Fiore Adam G Sowalsky Massimo Loda X Shirley Liu Myles Brown Steven P Balk Xin Yuan

Fusion of the androgen receptor-regulated (AR-regulated) TMPRSS2 gene with ERG in prostate cancer (PCa) causes androgen-stimulated overexpression of ERG, an ETS transcription factor, but critical downstream effectors of ERG-mediating PCa development remain to be established. Expression of the SOX9 transcription factor correlated with TMPRSS2:ERG fusion in 3 independent PCa cohorts, and ERG-depe...

2017
Justin M. Roberts Rebeca San Martin D. Piyarathna Badrajee James G. MacKrell Guilherme V. Rocha Jeffery A. Dodge Cristian Coarfa Venkatesh Krishnan David R. Rowley Nancy L. Weigel

Whether vitamin D is chemopreventive and/or has potential therapeutically in prostate cancer is unresolved. One confounding factor is that many prostate cancers express a TMPRSS2:ERG fusion gene whose expression is increased both by androgens and by vitamin D receptor (VDR) activation. Two challenges that limit VDR agonist use clinically are hypercalcemia and the cooperation of VDR with ERG to ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2014
Shan Wang Rahul K Kollipara Nishi Srivastava Rui Li Preethi Ravindranathan Elizabeth Hernandez Eva Freeman Caroline G Humphries Payal Kapur Yair Lotan Ladan Fazli Martin E Gleave Stephen R Plymate Ganesh V Raj Jer-Tsong Hsieh Ralf Kittler

The transcription factor E-twenty-six related gene (ERG), which is overexpressed through gene fusion with the androgen-responsive gene transmembrane protease, serine 2 (TMPRSS2) in ∼40% of prostate tumors, is a key driver of prostate carcinogenesis. Ablation of ERG would disrupt a key oncogenic transcriptional circuit and could be a promising therapeutic strategy for prostate cancer treatment. ...

2011
Franclim R. Ribeiro Paula Paulo Vera L. Costa João D. Barros-Silva João Ramalho-Carvalho Carmen Jerónimo Rui Henrique Guro E. Lind Rolf I. Skotheim Ragnhild A. Lothe Manuel R. Teixeira

A large percentage of prostate cancers harbor TMPRSS2-ERG gene fusions, leading to aberrant overexpression of the transcription factor ERG. The target genes deregulated by this rearrangement, however, remain mostly unknown. To address this subject we performed genome-wide mRNA expression analysis on 6 non-malignant prostate samples and 24 prostate carcinomas with (n = 16) and without (n = 8) TM...

Journal: :The Prostate 2016
Lijuan Xiao Rainer B Lanz Anna Frolov Patricia D Castro Zheng Zhang Baijun Dong Wei Xue Sung Yun Jung John P Lydon Dean P Edwards Michael A Mancini Qin Feng Michael M Ittmann Bin He

BACKGROUND TMPRSS2-ERG fusion occurs in about half of prostate cancers and results in over-expression of the oncogenic ERG protein in the prostate. The mechanism by which ERG contributes to prostate cancer initiation and progression remains largely unknown. Because ERG is a transcriptional activator, we reasoned that the target genes regulated by ERG could contribute to prostate cancer developm...

Journal: :American journal of clinical pathology 2014
Rachel M Hagen Patricia Adamo Saima Karamat Jon Oxley Jonathan J Aning David Gillatt Raj Persad Michael R Ladomery Anthony Rhodes

OBJECTIVES The proto-oncogene ETS-related gene (ERG) is consistently overexpressed in prostate cancer. Alternatively spliced isoforms of ERG have variable biological activities; inclusion of exon 11 (72 base pairs [bp]) is associated with aggressiveness and progression of disease. Exon 10 (81 bp) has also been shown to be alternatively spliced. Within this study, we assess whether ERG protein, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید